<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title></title>
  <meta name="description" content="" />
  <meta name="generator" content="bookdown 0.13 and GitBook 2.6.7" />

  <meta property="og:title" content="" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="" />
  
  
  




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="brachy.html"/>
<link rel="next" href="qa.html"/>
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />







<script src="libs/kePrint-0.0.1/kePrint.js"></script>



<link rel="stylesheet" href="style.css" type="text/css" />
<link rel="stylesheet" href="font-awesome.min.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">Practical Medical Physics</a></li>

<li class="divider"></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Welcome</a></li>
<li class="chapter" data-level="1" data-path="introduction.html"><a href="introduction.html"><i class="fa fa-check"></i><b>1</b> Introduction</a><ul>
<li class="chapter" data-level="1.1" data-path="introduction.html"><a href="introduction.html#constant"><i class="fa fa-check"></i><b>1.1</b> Physics constants</a></li>
<li class="chapter" data-level="1.2" data-path="introduction.html"><a href="introduction.html#atomic-rep"><i class="fa fa-check"></i><b>1.2</b> Atomic Representation</a></li>
<li class="chapter" data-level="1.3" data-path="introduction.html"><a href="introduction.html#stability"><i class="fa fa-check"></i><b>1.3</b> Stability</a></li>
<li class="chapter" data-level="1.4" data-path="introduction.html"><a href="introduction.html#mass-defect"><i class="fa fa-check"></i><b>1.4</b> Mass Defect</a></li>
<li class="chapter" data-level="1.5" data-path="introduction.html"><a href="introduction.html#einstein"><i class="fa fa-check"></i><b>1.5</b> High energy charged particles</a></li>
<li class="chapter" data-level="1.6" data-path="introduction.html"><a href="introduction.html#high-E-photon"><i class="fa fa-check"></i><b>1.6</b> High energy photons</a></li>
<li class="chapter" data-level="1.7" data-path="introduction.html"><a href="introduction.html#electron-shell"><i class="fa fa-check"></i><b>1.7</b> Electron Shell</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="nut.html"><a href="nut.html"><i class="fa fa-check"></i><b>2</b> Nuclear Transformation</a><ul>
<li class="chapter" data-level="2.1" data-path="nut.html"><a href="nut.html#decays"><i class="fa fa-check"></i><b>2.1</b> Nuclear Decay (disintegration)</a><ul>
<li class="chapter" data-level="2.1.1" data-path="nut.html"><a href="nut.html#alpha"><i class="fa fa-check"></i><b>2.1.1</b> Alpha-decay</a></li>
<li class="chapter" data-level="2.1.2" data-path="nut.html"><a href="nut.html#beta"><i class="fa fa-check"></i><b>2.1.2</b> Beta-decay</a></li>
<li class="chapter" data-level="2.1.3" data-path="nut.html"><a href="nut.html#ec"><i class="fa fa-check"></i><b>2.1.3</b> Electron capture</a></li>
<li class="chapter" data-level="2.1.4" data-path="nut.html"><a href="nut.html#gamma"><i class="fa fa-check"></i><b>2.1.4</b> Gamma decay</a></li>
</ul></li>
<li class="chapter" data-level="2.2" data-path="nut.html"><a href="nut.html#activity"><i class="fa fa-check"></i><b>2.2</b> Activity</a><ul>
<li class="chapter" data-level="2.2.1" data-path="nut.html"><a href="nut.html#sa"><i class="fa fa-check"></i><b>2.2.1</b> Special activity</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="prox.html"><a href="prox.html"><i class="fa fa-check"></i><b>3</b> Production of X-rays</a><ul>
<li class="chapter" data-level="3.1" data-path="prox.html"><a href="prox.html#history"><i class="fa fa-check"></i><b>3.1</b> History</a></li>
<li class="chapter" data-level="3.2" data-path="prox.html"><a href="prox.html#conventional-x-ray-tubes"><i class="fa fa-check"></i><b>3.2</b> Conventional x-ray tubes</a><ul>
<li class="chapter" data-level="3.2.1" data-path="prox.html"><a href="prox.html#electron-source-cathode"><i class="fa fa-check"></i><b>3.2.1</b> Electron Source (Cathode)</a></li>
<li class="chapter" data-level="3.2.2" data-path="prox.html"><a href="prox.html#high-voltage"><i class="fa fa-check"></i><b>3.2.2</b> High voltage</a></li>
<li class="chapter" data-level="3.2.3" data-path="prox.html"><a href="prox.html#x-rayproduction"><i class="fa fa-check"></i><b>3.2.3</b> Target for x-ray production</a></li>
<li class="chapter" data-level="3.2.4" data-path="prox.html"><a href="prox.html#target-x-ray-spectra"><i class="fa fa-check"></i><b>3.2.4</b> Target X-ray spectra</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="4" data-path="gene.html"><a href="gene.html"><i class="fa fa-check"></i><b>4</b> Clinical Treatment Generators</a><ul>
<li class="chapter" data-level="4.1" data-path="gene.html"><a href="gene.html#history-1"><i class="fa fa-check"></i><b>4.1</b> History</a></li>
<li class="chapter" data-level="4.2" data-path="gene.html"><a href="gene.html#components"><i class="fa fa-check"></i><b>4.2</b> Components</a><ul>
<li class="chapter" data-level="4.2.1" data-path="gene.html"><a href="gene.html#egun"><i class="fa fa-check"></i><b>4.2.1</b> Electron gun</a></li>
<li class="chapter" data-level="4.2.2" data-path="gene.html"><a href="gene.html#mvamp"><i class="fa fa-check"></i><b>4.2.2</b> Microwave amplifier</a></li>
<li class="chapter" data-level="4.2.3" data-path="gene.html"><a href="gene.html#waveguide"><i class="fa fa-check"></i><b>4.2.3</b> Waveguide</a></li>
<li class="chapter" data-level="4.2.4" data-path="gene.html"><a href="gene.html#bending"><i class="fa fa-check"></i><b>4.2.4</b> Bending magnet</a></li>
<li class="chapter" data-level="4.2.5" data-path="gene.html"><a href="gene.html#primary-collimator"><i class="fa fa-check"></i><b>4.2.5</b> Primary collimator</a></li>
<li class="chapter" data-level="4.2.6" data-path="gene.html"><a href="gene.html#target-carousel"><i class="fa fa-check"></i><b>4.2.6</b> Target carousel</a></li>
<li class="chapter" data-level="4.2.7" data-path="gene.html"><a href="gene.html#ion-chamber"><i class="fa fa-check"></i><b>4.2.7</b> Ion chamber</a></li>
<li class="chapter" data-level="4.2.8" data-path="gene.html"><a href="gene.html#jaws-and-mlcs"><i class="fa fa-check"></i><b>4.2.8</b> Jaws and MLCs</a></li>
<li class="chapter" data-level="4.2.9" data-path="gene.html"><a href="gene.html#auxiliary-system"><i class="fa fa-check"></i><b>4.2.9</b> Auxiliary system</a></li>
</ul></li>
<li class="chapter" data-level="4.3" data-path="gene.html"><a href="gene.html#penumbra"><i class="fa fa-check"></i><b>4.3</b> Penumbra</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="inter.html"><a href="inter.html"><i class="fa fa-check"></i><b>5</b> Interaction</a><ul>
<li class="chapter" data-level="5.1" data-path="inter.html"><a href="inter.html#photon-beam-attenuation"><i class="fa fa-check"></i><b>5.1</b> Photon beam attenuation</a><ul>
<li class="chapter" data-level="5.1.1" data-path="inter.html"><a href="inter.html#photo-el"><i class="fa fa-check"></i><b>5.1.1</b> Photoelectric interactions</a></li>
<li class="chapter" data-level="5.1.2" data-path="inter.html"><a href="inter.html#compton1"><i class="fa fa-check"></i><b>5.1.2</b> Compton interactions</a></li>
<li class="chapter" data-level="5.1.3" data-path="inter.html"><a href="inter.html#pair"><i class="fa fa-check"></i><b>5.1.3</b> Pair production</a></li>
</ul></li>
<li class="chapter" data-level="5.2" data-path="inter.html"><a href="inter.html#charged-particle-interactions"><i class="fa fa-check"></i><b>5.2</b> Charged particle interactions</a></li>
</ul></li>
<li class="chapter" data-level="6" data-path="measurement.html"><a href="measurement.html"><i class="fa fa-check"></i><b>6</b> Measurement of Ionizing Radiation</a><ul>
<li class="chapter" data-level="6.1" data-path="measurement.html"><a href="measurement.html#collection-volume"><i class="fa fa-check"></i><b>6.1</b> Collection volume</a></li>
<li class="chapter" data-level="6.2" data-path="measurement.html"><a href="measurement.html#signal-of-an-ion-chamber"><i class="fa fa-check"></i><b>6.2</b> Signal of an ion chamber</a></li>
<li class="chapter" data-level="6.3" data-path="measurement.html"><a href="measurement.html#temperature-and-pressure-correction"><i class="fa fa-check"></i><b>6.3</b> Temperature and pressure correction</a></li>
<li class="chapter" data-level="6.4" data-path="measurement.html"><a href="measurement.html#guard-electrode"><i class="fa fa-check"></i><b>6.4</b> Guard electrode</a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="quality.html"><a href="quality.html"><i class="fa fa-check"></i><b>7</b> Quality of X-rays</a></li>
<li class="chapter" data-level="8" data-path="dose.html"><a href="dose.html"><i class="fa fa-check"></i><b>8</b> Absorbed Dose</a><ul>
<li class="chapter" data-level="8.1" data-path="dose.html"><a href="dose.html#fluence-kerma"><i class="fa fa-check"></i><b>8.1</b> Fluence, Energy fluence, KERMA</a></li>
<li class="chapter" data-level="8.2" data-path="dose.html"><a href="dose.html#optical-density"><i class="fa fa-check"></i><b>8.2</b> Optical density</a></li>
<li class="chapter" data-level="8.3" data-path="dose.html"><a href="dose.html#q9-od"><i class="fa fa-check"></i><b>8.3</b> Q9 OD</a></li>
</ul></li>
<li class="chapter" data-level="9" data-path="distribution.html"><a href="distribution.html"><i class="fa fa-check"></i><b>9</b> Dose Distributions</a><ul>
<li class="chapter" data-level="9.1" data-path="distribution.html"><a href="distribution.html#tar"><i class="fa fa-check"></i><b>9.1</b> TAR</a></li>
</ul></li>
<li class="chapter" data-level="10" data-path="dosecalc.html"><a href="dosecalc.html"><i class="fa fa-check"></i><b>10</b> Dose calcuation</a></li>
<li class="chapter" data-level="11" data-path="planning1.html"><a href="planning1.html"><i class="fa fa-check"></i><b>11</b> Treatment Planning I: Isodose Distribution and Plan Evaluation</a><ul>
<li class="chapter" data-level="11.1" data-path="gene.html"><a href="gene.html#penumbra"><i class="fa fa-check"></i><b>11.1</b> Penumbra</a></li>
<li class="chapter" data-level="11.2" data-path="planning1.html"><a href="planning1.html#wedges"><i class="fa fa-check"></i><b>11.2</b> Wedges</a><ul>
<li class="chapter" data-level="11.2.1" data-path="planning1.html"><a href="planning1.html#wf"><i class="fa fa-check"></i><b>11.2.1</b> Wedge factors</a></li>
</ul></li>
<li class="chapter" data-level="11.3" data-path="planning1.html"><a href="planning1.html#treatment-techniques"><i class="fa fa-check"></i><b>11.3</b> Treatment techniques</a><ul>
<li class="chapter" data-level="11.3.1" data-path="planning1.html"><a href="planning1.html#integral-dose"><i class="fa fa-check"></i><b>11.3.1</b> Integral dose</a></li>
</ul></li>
<li class="chapter" data-level="11.4" data-path="planning1.html"><a href="planning1.html#plan-evaluation"><i class="fa fa-check"></i><b>11.4</b> Plan evaluation</a><ul>
<li class="chapter" data-level="11.4.1" data-path="planning1.html"><a href="planning1.html#dose-volume-histogram"><i class="fa fa-check"></i><b>11.4.1</b> Dose-volume histogram</a></li>
<li class="chapter" data-level="11.4.2" data-path="planning1.html"><a href="planning1.html#tcpntcp"><i class="fa fa-check"></i><b>11.4.2</b> TCP/NTCP</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="12" data-path="planning2.html"><a href="planning2.html"><i class="fa fa-check"></i><b>12</b> Treatment Planning II: Patient Data, Corrections, and Setup</a><ul>
<li class="chapter" data-level="12.1" data-path="planning2.html"><a href="planning2.html#ct"><i class="fa fa-check"></i><b>12.1</b> Computed tomography</a></li>
<li class="chapter" data-level="12.2" data-path="planning2.html"><a href="planning2.html#inhomogeneity"><i class="fa fa-check"></i><b>12.2</b> Inhomogeneity</a></li>
<li class="chapter" data-level="12.3" data-path="planning2.html"><a href="planning2.html#range"><i class="fa fa-check"></i><b>12.3</b> Range</a></li>
<li class="chapter" data-level="12.4" data-path="planning2.html"><a href="planning2.html#mri"><i class="fa fa-check"></i><b>12.4</b> MRI</a></li>
<li class="chapter" data-level="12.5" data-path="planning2.html"><a href="planning2.html#pet"><i class="fa fa-check"></i><b>12.5</b> PET</a></li>
</ul></li>
<li class="chapter" data-level="13" data-path="planning3.html"><a href="planning3.html"><i class="fa fa-check"></i><b>13</b> Treatment Planning III: Field shaping, skin dose, and field separation</a><ul>
<li class="chapter" data-level="13.1" data-path="planning3.html"><a href="planning3.html#hvl"><i class="fa fa-check"></i><b>13.1</b> HVL</a></li>
<li class="chapter" data-level="13.2" data-path="planning3.html"><a href="planning3.html#q2-3-4-and-7-range"><i class="fa fa-check"></i><b>13.2</b> Q2, 3, 4, and 7 Range</a></li>
</ul></li>
<li class="chapter" data-level="14" data-path="electron.html"><a href="electron.html"><i class="fa fa-check"></i><b>14</b> Electron</a><ul>
<li class="chapter" data-level="14.1" data-path="electron.html"><a href="electron.html#history-2"><i class="fa fa-check"></i><b>14.1</b> History</a></li>
<li class="chapter" data-level="14.2" data-path="electron.html"><a href="electron.html#treatment-sites"><i class="fa fa-check"></i><b>14.2</b> Treatment Sites</a></li>
<li class="chapter" data-level="14.3" data-path="electron.html"><a href="electron.html#e-interactions"><i class="fa fa-check"></i><b>14.3</b> Interactions</a></li>
<li class="chapter" data-level="14.4" data-path="electron.html"><a href="electron.html#e-delivery"><i class="fa fa-check"></i><b>14.4</b> Delivery</a></li>
<li class="chapter" data-level="14.5" data-path="electron.html"><a href="electron.html#beam-quality"><i class="fa fa-check"></i><b>14.5</b> Beam quality</a></li>
<li class="chapter" data-level="14.6" data-path="electron.html"><a href="electron.html#internal-shielding"><i class="fa fa-check"></i><b>14.6</b> Internal shielding</a></li>
<li class="chapter" data-level="14.7" data-path="electron.html"><a href="electron.html#total-skin-electron-irradiation-tsei"><i class="fa fa-check"></i><b>14.7</b> Total skin electron irradiation (TSEI)</a></li>
<li class="chapter" data-level="14.8" data-path="electron.html"><a href="electron.html#e-solu"><i class="fa fa-check"></i><b>14.8</b> Solutions</a></li>
</ul></li>
<li class="chapter" data-level="15" data-path="brachy.html"><a href="brachy.html"><i class="fa fa-check"></i><b>15</b> Brachytherapy</a><ul>
<li class="chapter" data-level="15.1" data-path="brachy.html"><a href="brachy.html#important-things-to-know"><i class="fa fa-check"></i><b>15.1</b> Important things to know</a></li>
<li class="chapter" data-level="15.2" data-path="brachy.html"><a href="brachy.html#isotopes"><i class="fa fa-check"></i><b>15.2</b> Isotopes</a><ul>
<li class="chapter" data-level="15.2.1" data-path="brachy.html"><a href="brachy.html#radium-sources"><i class="fa fa-check"></i><b>15.2.1</b> Radium sources</a></li>
<li class="chapter" data-level="15.2.2" data-path="brachy.html"><a href="brachy.html#radium-substitutes"><i class="fa fa-check"></i><b>15.2.2</b> Radium substitutes</a></li>
</ul></li>
<li class="chapter" data-level="15.3" data-path="brachy.html"><a href="brachy.html#source-strength"><i class="fa fa-check"></i><b>15.3</b> Source strength</a><ul>
<li class="chapter" data-level="15.3.1" data-path="brachy.html"><a href="brachy.html#sk"><i class="fa fa-check"></i><b>15.3.1</b> Unit: Air-kerma strength <span class="math inline">\(S_k\)</span></a></li>
</ul></li>
<li class="chapter" data-level="15.4" data-path="brachy.html"><a href="brachy.html#radiation-dose-from-brachytherpay-sources"><i class="fa fa-check"></i><b>15.4</b> Radiation dose from brachytherpay sources</a><ul>
<li class="chapter" data-level="15.4.1" data-path="brachy.html"><a href="brachy.html#from-exposure-rate"><i class="fa fa-check"></i><b>15.4.1</b> From exposure rate</a></li>
<li class="chapter" data-level="15.4.2" data-path="brachy.html"><a href="brachy.html#tg43"><i class="fa fa-check"></i><b>15.4.2</b> TG-43</a></li>
</ul></li>
<li class="chapter" data-level="15.5" data-path="brachy.html"><a href="brachy.html#biological-doses"><i class="fa fa-check"></i><b>15.5</b> Biological Doses</a></li>
<li class="chapter" data-level="15.6" data-path="brachy.html"><a href="brachy.html#ldr-solutions"><i class="fa fa-check"></i><b>15.6</b> Solutions</a></li>
<li class="chapter" data-level="15.7" data-path="brachy.html"><a href="brachy.html#traceability"><i class="fa fa-check"></i><b>15.7</b> Traceability</a></li>
<li class="chapter" data-level="15.8" data-path="brachy.html"><a href="brachy.html#tg-167"><i class="fa fa-check"></i><b>15.8</b> TG-167</a></li>
</ul></li>
<li class="chapter" data-level="16" data-path="protection.html"><a href="protection.html"><i class="fa fa-check"></i><b>16</b> Radiation Protection</a><ul>
<li class="chapter" data-level="16.1" data-path="protection.html"><a href="protection.html#agencies"><i class="fa fa-check"></i><b>16.1</b> Agencies</a><ul>
<li class="chapter" data-level="16.1.1" data-path="protection.html"><a href="protection.html#regulatory-agencies"><i class="fa fa-check"></i><b>16.1.1</b> Regulatory agencies</a></li>
<li class="chapter" data-level="16.1.2" data-path="protection.html"><a href="protection.html#advisory-bodies"><i class="fa fa-check"></i><b>16.1.2</b> Advisory bodies</a></li>
</ul></li>
<li class="chapter" data-level="16.2" data-path="protection.html"><a href="protection.html#sources-of-radiation-exposure"><i class="fa fa-check"></i><b>16.2</b> Sources of radiation exposure</a></li>
<li class="chapter" data-level="16.3" data-path="protection.html"><a href="protection.html#effects-of-radiation-exposure"><i class="fa fa-check"></i><b>16.3</b> Effects of Radiation Exposure</a><ul>
<li class="chapter" data-level="16.3.1" data-path="protection.html"><a href="protection.html#stochastic-probabilistic-effects"><i class="fa fa-check"></i><b>16.3.1</b> Stochastic (probabilistic) effects</a></li>
<li class="chapter" data-level="16.3.2" data-path="protection.html"><a href="protection.html#deterministic-radiation-effects"><i class="fa fa-check"></i><b>16.3.2</b> Deterministic radiation effects</a></li>
</ul></li>
<li class="chapter" data-level="16.4" data-path="protection.html"><a href="protection.html#dosimetric-quantities-for-radiation-safety"><i class="fa fa-check"></i><b>16.4</b> Dosimetric Quantities for Radiation Safety</a><ul>
<li class="chapter" data-level="16.4.1" data-path="protection.html"><a href="protection.html#equivalent-dose"><i class="fa fa-check"></i><b>16.4.1</b> Equivalent dose</a></li>
<li class="chapter" data-level="16.4.2" data-path="protection.html"><a href="protection.html#effective-dose-e"><i class="fa fa-check"></i><b>16.4.2</b> Effective dose (E)</a></li>
</ul></li>
<li class="chapter" data-level="16.5" data-path="protection.html"><a href="protection.html#principles-of-radiation-protection"><i class="fa fa-check"></i><b>16.5</b> Principles of Radiation Protection</a><ul>
<li class="chapter" data-level="16.5.1" data-path="protection.html"><a href="protection.html#tds-rule"><i class="fa fa-check"></i><b>16.5.1</b> TDS rule</a></li>
<li class="chapter" data-level="16.5.2" data-path="protection.html"><a href="protection.html#alara"><i class="fa fa-check"></i><b>16.5.2</b> ALARA</a></li>
<li class="chapter" data-level="16.5.3" data-path="protection.html"><a href="protection.html#dose-limits"><i class="fa fa-check"></i><b>16.5.3</b> Dose limits</a></li>
</ul></li>
<li class="chapter" data-level="16.6" data-path="protection.html"><a href="protection.html#shielding-calculation"><i class="fa fa-check"></i><b>16.6</b> Shielding Calculation</a><ul>
<li class="chapter" data-level="16.6.1" data-path="protection.html"><a href="protection.html#dosimetric-quantities-for-shielding-design"><i class="fa fa-check"></i><b>16.6.1</b> Dosimetric Quantities for Shielding Design</a></li>
<li class="chapter" data-level="16.6.2" data-path="protection.html"><a href="protection.html#workload-w"><i class="fa fa-check"></i><b>16.6.2</b> Workload (W)</a></li>
<li class="chapter" data-level="16.6.3" data-path="protection.html"><a href="protection.html#occupancy-factor"><i class="fa fa-check"></i><b>16.6.3</b> Occupancy factor</a></li>
<li class="chapter" data-level="16.6.4" data-path="protection.html"><a href="protection.html#use-factor-u"><i class="fa fa-check"></i><b>16.6.4</b> Use factor (U)</a></li>
<li class="chapter" data-level="16.6.5" data-path="protection.html"><a href="protection.html#primary-barrier"><i class="fa fa-check"></i><b>16.6.5</b> Primary barrier</a></li>
<li class="chapter" data-level="16.6.6" data-path="protection.html"><a href="protection.html#secondary-barrier"><i class="fa fa-check"></i><b>16.6.6</b> Secondary barrier</a></li>
<li class="chapter" data-level="16.6.7" data-path="protection.html"><a href="protection.html#conservation"><i class="fa fa-check"></i><b>16.6.7</b> Conservation</a></li>
</ul></li>
<li class="chapter" data-level="16.7" data-path="protection.html"><a href="protection.html#survey"><i class="fa fa-check"></i><b>16.7</b> Survey</a><ul>
<li class="chapter" data-level="16.7.1" data-path="protection.html"><a href="protection.html#detectors"><i class="fa fa-check"></i><b>16.7.1</b> Detectors</a></li>
<li class="chapter" data-level="16.7.2" data-path="protection.html"><a href="protection.html#patient-release"><i class="fa fa-check"></i><b>16.7.2</b> Patient release</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="17" data-path="qa.html"><a href="qa.html"><i class="fa fa-check"></i><b>17</b> QA</a><ul>
<li class="chapter" data-level="17.1" data-path="qa.html"><a href="qa.html#patient-specific-qa"><i class="fa fa-check"></i><b>17.1</b> Patient-specific QA</a></li>
<li class="chapter" data-level="17.2" data-path="qa.html"><a href="qa.html#quality-and-safety"><i class="fa fa-check"></i><b>17.2</b> Quality and safety</a></li>
<li class="chapter" data-level="17.3" data-path="qa.html"><a href="qa.html#tg-100"><i class="fa fa-check"></i><b>17.3</b> TG-100</a></li>
<li class="chapter" data-level="17.4" data-path="qa.html"><a href="qa.html#tg-275"><i class="fa fa-check"></i><b>17.4</b> TG-275</a></li>
</ul></li>
<li class="chapter" data-level="18" data-path="tbi.html"><a href="tbi.html"><i class="fa fa-check"></i><b>18</b> TBI</a></li>
<li class="chapter" data-level="19" data-path="crt.html"><a href="crt.html"><i class="fa fa-check"></i><b>19</b> Three-dimensional conformal radiotherapy</a><ul>
<li class="chapter" data-level="19.1" data-path="crt.html"><a href="crt.html#icru-reference-point"><i class="fa fa-check"></i><b>19.1</b> ICRU reference point</a></li>
<li class="chapter" data-level="19.2" data-path="crt.html"><a href="crt.html#image-operations"><i class="fa fa-check"></i><b>19.2</b> Image operations</a><ul>
<li class="chapter" data-level="19.2.1" data-path="crt.html"><a href="crt.html#glossary-tg-132"><i class="fa fa-check"></i><b>19.2.1</b> Glossary (<a href="https://aapm.onlinelibrary.wiley.com/doi/full/10.1002/mp.12256">TG-132</a>)</a></li>
<li class="chapter" data-level="19.2.2" data-path="crt.html"><a href="crt.html#techniques-for-image-registration"><i class="fa fa-check"></i><b>19.2.2</b> Techniques for image registration</a></li>
<li class="chapter" data-level="19.2.3" data-path="crt.html"><a href="crt.html#qa-for-image-registration"><i class="fa fa-check"></i><b>19.2.3</b> QA for image registration</a></li>
<li class="chapter" data-level="19.2.4" data-path="crt.html"><a href="crt.html#dir"><i class="fa fa-check"></i><b>19.2.4</b> Deformable image registration</a></li>
</ul></li>
<li class="chapter" data-level="19.3" data-path="crt.html"><a href="crt.html#iseg"><i class="fa fa-check"></i><b>19.3</b> Image segmentation</a></li>
<li class="chapter" data-level="19.4" data-path="crt.html"><a href="crt.html#cumulative-dvh"><i class="fa fa-check"></i><b>19.4</b> Cumulative DVH</a></li>
<li class="chapter" data-level="19.5" data-path="crt.html"><a href="crt.html#differential-dvh"><i class="fa fa-check"></i><b>19.5</b> Differential DVH</a></li>
</ul></li>
<li class="chapter" data-level="20" data-path="imrt.html"><a href="imrt.html"><i class="fa fa-check"></i><b>20</b> IMRT</a><ul>
<li class="chapter" data-level="20.1" data-path="imrt.html"><a href="imrt.html#imrt"><i class="fa fa-check"></i><b>20.1</b> IMRT</a></li>
<li class="chapter" data-level="20.2" data-path="imrt.html"><a href="imrt.html#psqa"><i class="fa fa-check"></i><b>20.2</b> IMRT QA</a></li>
<li class="chapter" data-level="20.3" data-path="imrt.html"><a href="imrt.html#patient-specific-plan-qa-pspa-or-imrt-qa"><i class="fa fa-check"></i><b>20.3</b> Patient-specific Plan QA (PSPA) or IMRT QA</a><ul>
<li class="chapter" data-level="20.3.1" data-path="imrt.html"><a href="imrt.html#devices"><i class="fa fa-check"></i><b>20.3.1</b> Devices</a></li>
<li class="chapter" data-level="20.3.2" data-path="imrt.html"><a href="imrt.html#evaluation-methods-hccf_documents_qaspecific-imrt-qa.doc-transmission-or-leakage-q4-mu-imrt-vs.3dcrt-q5-shielding-for-imrt-q8-q9-q10-mlc-tests-q12"><i class="fa fa-check"></i><b>20.3.2</b> Evaluation methods (H:CCF_DOCUMENTS_qaSpecific IMRT QA.doc) ## Transmission or leakage ## Q4 MU: IMRT vs. 3DCRT ## Q5 ## Shielding for IMRT ## ## Q8 ## Q9 ## Q10 ## MLC test(s) ## Q12</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="21" data-path="srs.html"><a href="srs.html"><i class="fa fa-check"></i><b>21</b> Stereotactic radiosurgery</a><ul>
<li class="chapter" data-level="21.1" data-path="srs.html"><a href="srs.html#milestones"><i class="fa fa-check"></i><b>21.1</b> Milestones</a></li>
<li class="chapter" data-level="21.2" data-path="srs.html"><a href="srs.html#definition-of-srs"><i class="fa fa-check"></i><b>21.2</b> Definition of SRS</a></li>
<li class="chapter" data-level="21.3" data-path="srs.html"><a href="srs.html#gamma-knife-gk-perfexiontm-and-icontm"><i class="fa fa-check"></i><b>21.3</b> GAMMA Knife (GK) Perfexion<sup>TM</sup> and Icon<sup>TM</sup></a><ul>
<li class="chapter" data-level="21.3.1" data-path="srs.html"><a href="srs.html#the-g-frame-and-its-accessories"><i class="fa fa-check"></i><b>21.3.1</b> The G frame and its accessories</a></li>
<li class="chapter" data-level="21.3.2" data-path="srs.html"><a href="srs.html#stereotactic-reference"><i class="fa fa-check"></i><b>21.3.2</b> Stereotactic reference</a></li>
<li class="chapter" data-level="21.3.3" data-path="srs.html"><a href="srs.html#steps-to-create-new-plan"><i class="fa fa-check"></i><b>21.3.3</b> Steps to create new plan</a></li>
</ul></li>
<li class="chapter" data-level="21.4" data-path="srs.html"><a href="srs.html#gk-white-papers"><i class="fa fa-check"></i><b>21.4</b> GK White Papers</a><ul>
<li class="chapter" data-level="21.4.1" data-path="srs.html"><a href="srs.html#accuracy-of-co-registration-of-planning-images-with-cone-beam-ct-images"><i class="fa fa-check"></i><b>21.4.1</b> Accuracy of co-registration of planning images with Cone Beam CT images</a></li>
<li class="chapter" data-level="21.4.2" data-path="srs.html"><a href="srs.html#automatic-positional-delivery-correction-using-a-stereotactic-cbct-in-gk-icontm"><i class="fa fa-check"></i><b>21.4.2</b> Automatic positional delivery correction using a stereotactic CBCT in GK Icon<sup>TM</sup></a></li>
</ul></li>
<li class="chapter" data-level="21.5" data-path="srs.html"><a href="srs.html#gk-troubleshooting"><i class="fa fa-check"></i><b>21.5</b> GK Troubleshooting</a></li>
<li class="chapter" data-level="21.6" data-path="srs.html"><a href="srs.html#qa-of-gk"><i class="fa fa-check"></i><b>21.6</b> QA of GK</a><ul>
<li class="chapter" data-level="21.6.1" data-path="srs.html"><a href="srs.html#prescision-and-accuracy"><i class="fa fa-check"></i><b>21.6.1</b> Prescision and accuracy</a></li>
</ul></li>
<li class="chapter" data-level="21.7" data-path="srs.html"><a href="srs.html#commissioning-of-gk"><i class="fa fa-check"></i><b>21.7</b> Commissioning of GK</a></li>
<li class="chapter" data-level="21.8" data-path="srs.html"><a href="srs.html#preparation-of-gk-treatment-planning"><i class="fa fa-check"></i><b>21.8</b> Preparation of GK Treatment Planning</a><ul>
<li class="chapter" data-level="21.8.1" data-path="srs.html"><a href="srs.html#frame-application-model-c"><i class="fa fa-check"></i><b>21.8.1</b> Frame Application: model C</a></li>
<li class="chapter" data-level="21.8.2" data-path="srs.html"><a href="srs.html#frame-application-perfexion"><i class="fa fa-check"></i><b>21.8.2</b> Frame application: Perfexion</a></li>
</ul></li>
<li class="chapter" data-level="21.9" data-path="srs.html"><a href="srs.html#gk-plan-indices"><i class="fa fa-check"></i><b>21.9</b> GK Plan Indices</a><ul>
<li class="chapter" data-level="21.9.1" data-path="srs.html"><a href="srs.html#systematic-errors"><i class="fa fa-check"></i><b>21.9.1</b> Systematic Errors</a></li>
</ul></li>
<li class="chapter" data-level="21.10" data-path="srs.html"><a href="srs.html#linac-based-srs"><i class="fa fa-check"></i><b>21.10</b> Linac-based SRS</a><ul>
<li class="chapter" data-level="21.10.1" data-path="srs.html"><a href="srs.html#cone-based"><i class="fa fa-check"></i><b>21.10.1</b> Cone-based</a></li>
</ul></li>
<li class="chapter" data-level="21.11" data-path="srs.html"><a href="srs.html#diesease-sites-treatment-with-srs"><i class="fa fa-check"></i><b>21.11</b> Diesease sites treatment with SRS</a><ul>
<li class="chapter" data-level="21.11.1" data-path="srs.html"><a href="srs.html#acoustic-neuoromas"><i class="fa fa-check"></i><b>21.11.1</b> Acoustic neuoromas</a></li>
<li class="chapter" data-level="21.11.2" data-path="srs.html"><a href="srs.html#arteriovenous-malforamtions-avm"><i class="fa fa-check"></i><b>21.11.2</b> Arteriovenous malforamtions (AVM)</a></li>
<li class="chapter" data-level="21.11.3" data-path="srs.html"><a href="srs.html#brain-metastases"><i class="fa fa-check"></i><b>21.11.3</b> Brain metastases</a></li>
<li class="chapter" data-level="21.11.4" data-path="srs.html"><a href="srs.html#malignant-gliomas"><i class="fa fa-check"></i><b>21.11.4</b> Malignant gliomas</a></li>
<li class="chapter" data-level="21.11.5" data-path="srs.html"><a href="srs.html#menningiomas"><i class="fa fa-check"></i><b>21.11.5</b> Menningiomas</a></li>
<li class="chapter" data-level="21.11.6" data-path="srs.html"><a href="srs.html#pituitary-tumors"><i class="fa fa-check"></i><b>21.11.6</b> Pituitary tumors</a></li>
<li class="chapter" data-level="21.11.7" data-path="srs.html"><a href="srs.html#unilateral-vestibular-schwannomas"><i class="fa fa-check"></i><b>21.11.7</b> Unilateral Vestibular Schwannomas</a></li>
<li class="chapter" data-level="21.11.8" data-path="srs.html"><a href="srs.html#uveal-melanomas"><i class="fa fa-check"></i><b>21.11.8</b> Uveal melanomas</a></li>
<li class="chapter" data-level="21.11.9" data-path="srs.html"><a href="srs.html#trigeminal-neuralgia"><i class="fa fa-check"></i><b>21.11.9</b> Trigeminal neuralgia</a></li>
</ul></li>
<li class="chapter" data-level="21.12" data-path="srs.html"><a href="srs.html#dose-fall-off"><i class="fa fa-check"></i><b>21.12</b> Dose fall-off</a></li>
<li class="chapter" data-level="21.13" data-path="srs.html"><a href="srs.html#required-measurements-for-commissioning-a-srssbrt-program"><i class="fa fa-check"></i><b>21.13</b> Required measurements for commissioning a SRS/SBRT program</a></li>
</ul></li>
<li class="chapter" data-level="22" data-path="sbrt.html"><a href="sbrt.html"><i class="fa fa-check"></i><b>22</b> SBRT</a><ul>
<li class="chapter" data-level="22.1" data-path="sbrt.html"><a href="sbrt.html#history-3"><i class="fa fa-check"></i><b>22.1</b> History</a></li>
<li class="chapter" data-level="22.2" data-path="sbrt.html"><a href="sbrt.html#radiobiology-of-albative-fractionation"><i class="fa fa-check"></i><b>22.2</b> Radiobiology of Albative Fractionation</a></li>
<li class="chapter" data-level="22.3" data-path="sbrt.html"><a href="sbrt.html#technical-aspects-of-sbrt"><i class="fa fa-check"></i><b>22.3</b> Technical Aspects of SBRT</a><ul>
<li class="chapter" data-level="22.3.1" data-path="sbrt.html"><a href="sbrt.html#immobilization-and-target-motion-issues-related-to-sbrt"><i class="fa fa-check"></i><b>22.3.1</b> Immobilization and Target Motion Issues Related to SBRT</a></li>
<li class="chapter" data-level="22.3.2" data-path="sbrt.html"><a href="sbrt.html#stereotactic-reference-1"><i class="fa fa-check"></i><b>22.3.2</b> Stereotactic reference</a></li>
<li class="chapter" data-level="22.3.3" data-path="sbrt.html"><a href="sbrt.html#steps-to-create-new-plan-1"><i class="fa fa-check"></i><b>22.3.3</b> Steps to create new plan</a></li>
</ul></li>
<li class="chapter" data-level="22.4" data-path="sbrt.html"><a href="sbrt.html#dose-fall-off-1"><i class="fa fa-check"></i><b>22.4</b> Dose fall-off</a></li>
<li class="chapter" data-level="22.5" data-path="sbrt.html"><a href="sbrt.html#required-measurements-for-commissioning-a-srssbrt-program-1"><i class="fa fa-check"></i><b>22.5</b> Required measurements for commissioning a SRS/SBRT program</a></li>
</ul></li>
<li class="chapter" data-level="23" data-path="hdr.html"><a href="hdr.html"><i class="fa fa-check"></i><b>23</b> HDR</a><ul>
<li class="chapter" data-level="23.1" data-path="hdr.html"><a href="hdr.html#hdr-vs.ldr"><i class="fa fa-check"></i><b>23.1</b> HDR vs. LDR</a></li>
<li class="chapter" data-level="23.2" data-path="hdr.html"><a href="hdr.html#hdr-qa"><i class="fa fa-check"></i><b>23.2</b> HDR-QA</a><ul>
<li class="chapter" data-level="23.2.1" data-path="hdr.html"><a href="hdr.html#daily-device-qa"><i class="fa fa-check"></i><b>23.2.1</b> Daily (device) QA</a></li>
<li class="chapter" data-level="23.2.2" data-path="hdr.html"><a href="hdr.html#pretreatment-qa-tg-59"><i class="fa fa-check"></i><b>23.2.2</b> Pretreatment QA (TG-59)</a></li>
<li class="chapter" data-level="23.2.3" data-path="hdr.html"><a href="hdr.html#hdr-source-change"><i class="fa fa-check"></i><b>23.2.3</b> Source change</a></li>
<li class="chapter" data-level="23.2.4" data-path="hdr.html"><a href="hdr.html#medical-events"><i class="fa fa-check"></i><b>23.2.4</b> Medical Events</a></li>
</ul></li>
<li class="chapter" data-level="23.3" data-path="hdr.html"><a href="hdr.html#sources"><i class="fa fa-check"></i><b>23.3</b> Sources</a></li>
<li class="chapter" data-level="23.4" data-path="hdr.html"><a href="hdr.html#treatment-sites-1"><i class="fa fa-check"></i><b>23.4</b> Treatment sites</a><ul>
<li class="chapter" data-level="23.4.1" data-path="hdr.html"><a href="hdr.html#cervical"><i class="fa fa-check"></i><b>23.4.1</b> Cervical cancer</a></li>
<li class="chapter" data-level="23.4.2" data-path="hdr.html"><a href="hdr.html#endometrial-cancer"><i class="fa fa-check"></i><b>23.4.2</b> Endometrial cancer</a></li>
<li class="chapter" data-level="23.4.3" data-path="hdr.html"><a href="hdr.html#breast"><i class="fa fa-check"></i><b>23.4.3</b> Breast</a></li>
<li class="chapter" data-level="23.4.4" data-path="hdr.html"><a href="hdr.html#prostate"><i class="fa fa-check"></i><b>23.4.4</b> Prostate</a></li>
</ul></li>
<li class="chapter" data-level="23.5" data-path="hdr.html"><a href="hdr.html#oncentra-planning"><i class="fa fa-check"></i><b>23.5</b> Oncentra planning</a></li>
<li class="chapter" data-level="23.6" data-path="hdr.html"><a href="hdr.html#saftey-and-shielding-design"><i class="fa fa-check"></i><b>23.6</b> Saftey and shielding design</a></li>
<li class="chapter" data-level="23.7" data-path="hdr.html"><a href="hdr.html#solutions"><i class="fa fa-check"></i><b>23.7</b> Solutions</a></li>
</ul></li>
<li class="chapter" data-level="24" data-path="implants.html"><a href="implants.html"><i class="fa fa-check"></i><b>24</b> Implants</a><ul>
<li class="chapter" data-level="24.1" data-path="implants.html"><a href="implants.html#isotopes-1"><i class="fa fa-check"></i><b>24.1</b> Isotopes</a></li>
<li class="chapter" data-level="24.2" data-path="implants.html"><a href="implants.html#patient-release-1"><i class="fa fa-check"></i><b>24.2</b> Patient Release</a></li>
<li class="chapter" data-level="24.3" data-path="implants.html"><a href="implants.html#prostate-implants"><i class="fa fa-check"></i><b>24.3</b> Prostate implants</a></li>
<li class="chapter" data-level="24.4" data-path="implants.html"><a href="implants.html#y90"><i class="fa fa-check"></i><b>24.4</b> TheraSphere</a><ul>
<li class="chapter" data-level="24.4.1" data-path="implants.html"><a href="implants.html#before-treatment"><i class="fa fa-check"></i><b>24.4.1</b> Before treatment</a></li>
<li class="chapter" data-level="24.4.2" data-path="implants.html"><a href="implants.html#standard-model"><i class="fa fa-check"></i><b>24.4.2</b> Standard model</a></li>
<li class="chapter" data-level="24.4.3" data-path="implants.html"><a href="implants.html#after-treatment"><i class="fa fa-check"></i><b>24.4.3</b> After treatment</a></li>
</ul></li>
<li class="chapter" data-level="24.5" data-path="implants.html"><a href="implants.html#eye"><i class="fa fa-check"></i><b>24.5</b> Eye plaque planning</a></li>
</ul></li>
<li class="chapter" data-level="25" data-path="ivbt.html"><a href="ivbt.html"><i class="fa fa-check"></i><b>25</b> Intravascular BT</a></li>
<li class="chapter" data-level="26" data-path="igrt.html"><a href="igrt.html"><i class="fa fa-check"></i><b>26</b> IGRT</a><ul>
<li class="chapter" data-level="26.1" data-path="igrt.html"><a href="igrt.html#cyber-knife"><i class="fa fa-check"></i><b>26.1</b> Cyber Knife</a></li>
<li class="chapter" data-level="26.2" data-path="igrt.html"><a href="igrt.html#tg-180"><i class="fa fa-check"></i><b>26.2</b> TG 180</a><ul>
<li class="chapter" data-level="26.2.1" data-path="igrt.html"><a href="igrt.html#mv-imaging"><i class="fa fa-check"></i><b>26.2.1</b> MV imaging</a></li>
<li class="chapter" data-level="26.2.2" data-path="igrt.html"><a href="igrt.html#kv-imaging"><i class="fa fa-check"></i><b>26.2.2</b> kV imaging</a></li>
<li class="chapter" data-level="26.2.3" data-path="igrt.html"><a href="igrt.html#comparison"><i class="fa fa-check"></i><b>26.2.3</b> Comparison</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="27" data-path="proton.html"><a href="proton.html"><i class="fa fa-check"></i><b>27</b> Proton RT</a></li>
<li class="chapter" data-level="28" data-path="varian.html"><a href="varian.html"><i class="fa fa-check"></i><b>28</b> Varian</a><ul>
<li class="chapter" data-level="28.1" data-path="varian.html"><a href="varian.html#clinac-couch"><i class="fa fa-check"></i><b>28.1</b> Clinac couch</a></li>
</ul></li>
<li class="chapter" data-level="29" data-path="it.html"><a href="it.html"><i class="fa fa-check"></i><b>29</b> Information Technology</a><ul>
<li class="chapter" data-level="29.1" data-path="it.html"><a href="it.html#it-basics"><i class="fa fa-check"></i><b>29.1</b> IT basics</a></li>
<li class="chapter" data-level="29.2" data-path="it.html"><a href="it.html#dicom"><i class="fa fa-check"></i><b>29.2</b> DICOM</a></li>
<li class="chapter" data-level="29.3" data-path="it.html"><a href="it.html#database-basics"><i class="fa fa-check"></i><b>29.3</b> Database basics</a></li>
<li class="chapter" data-level="29.4" data-path="it.html"><a href="it.html#programming"><i class="fa fa-check"></i><b>29.4</b> Programming</a><ul>
<li class="chapter" data-level="29.4.1" data-path="it.html"><a href="it.html#unixos"><i class="fa fa-check"></i><b>29.4.1</b> Unix/OS</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="30" data-path="bed.html"><a href="bed.html"><i class="fa fa-check"></i><b>30</b> Radiobiology</a><ul>
<li class="chapter" data-level="30.1" data-path="bed.html"><a href="bed.html#step-to-lq-heaven"><i class="fa fa-check"></i><b>30.1</b> 7-Step to LQ heaven</a></li>
<li class="chapter" data-level="30.2" data-path="bed.html"><a href="bed.html#bed"><i class="fa fa-check"></i><b>30.2</b> BED</a></li>
<li class="chapter" data-level="30.3" data-path="introduction.html"><a href="introduction.html#introduction"><i class="fa fa-check"></i><b>30.3</b> Introduction</a><ul>
<li class="chapter" data-level="30.3.1" data-path="bed.html"><a href="bed.html#cell-survival-curve"><i class="fa fa-check"></i><b>30.3.1</b> Cell survival curve</a></li>
</ul></li>
</ul></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./"></a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="protection" class="section level1">
<h1><span class="header-section-number">Chapter 16</span> Radiation Protection</h1>
<blockquote>
<p>Although radiation is naturally present in our environment, it can have either <font color="green">beneficial</font> or <font color="red">harmful</font> effect, depending on its use and control.</p>
<footer>
— NRC websit
</footer>
</blockquote>
<div id="agencies" class="section level2">
<h2><span class="header-section-number">16.1</span> Agencies</h2>
<div id="regulatory-agencies" class="section level3">
<h3><span class="header-section-number">16.1.1</span> Regulatory agencies</h3>
<ul>
<li>United State Nuclear Regulatory Commission (U.S.NRC)
<ul>
<li>Naturally occurring radioisotopes</li>
<li>Reactor- and accelerator-produced radionuclides</li>
<li>Documentation (RT-related): Title 10 <a href="https://www.nrc.gov/reading-rm/doc-collections/cfr/">Code of Federal Regulations</a> (CFR) Part 19, 20, and 35</li>
</ul></li>
<li>States
<ul>
<li>X-ray – generating machines (CT simulator and Linac)</li>
<li>the NRC regulated materials (agreement states only; the NRC <a href="https://www.nrc.gov/reading-rm/basic-ref/glossary/agreement-state.html">definition</a>: an <db>agreement state</db> is a state that has signed an agreement with the NRC authorizing the State to regulate certain uses of radioactive materials within the State.)</li>
</ul></li>
<li>Food and Drug Administration (FDA)
<ul>
<li>Manufacture and sale of machines and TPS’s (501K clearance)</li>
</ul></li>
<li>Department of Transportation (DOT)
<ul>
<li>Safe transport of radioactive materials</li>
</ul></li>
</ul>
<p>Hospitials are typically under specific licenses of broad scope for byproduct material (“broad licenses”). The details can be found in <a href="https://www.nrc.gov/reading-rm/doc-collections/cfr/part033/index.html">10 CFR Part 33</a>. For CCF, we are under a <db>Type-A broad scope byproduct license</db>, which is a specific license authorizing receipt, acquisition, ownership, possession, use, and transfer of any chemical or physical form of the byproduct material specified in the license, but not exceeding quantities specified in the license, for purposes authorized by the Act. The quantities specified are usually in the <strong>multicurie</strong> range. There are also Type B and C specific license of broad scope for licensees in using one and/or two isotopes and limited quantities.</p>
<p class="question">
To apply for the Type-A broad license, a radiation safety committee should be established and consists of certain personnel. <em>Which of the following should not be part of the safety committee?</em> a) a radiation safety officer, b) an authorized user, c) department chairman, d) a representative of management who is neither the RSO nor an authorized user, and e) a nurse. <br></br> Answer: <ab>a), b), d), e)</ab>
</p>
</div>
<div id="advisory-bodies" class="section level3">
<h3><span class="header-section-number">16.1.2</span> Advisory bodies</h3>
<ul>
<li>International Atomic Energy Agency (IAEA)
<ul>
<li>Book “<a href="https://www.iaea.org/publications/7086/radiation-oncology-physics">Radiation Oncology Physics</a>” and its <a href="http://www-naweb.iaea.org/NAHU/DMRP/slides.html">slides</a> (one of best physics resources)</li>
</ul></li>
<li>International Commission on Radiological Protection (ICRP)
<ul>
<li>Proceedings of the Forth International Symposium on the System of Radiological Protection 2018</li>
<li>Publicatin 103 “The 2007 Recommendations of the International Commission on Radiological Protection”</li>
</ul></li>
<li>The International Commission of Radiation Units and Measurement (ICRU)
<ul>
<li>Report 79 “ROC Analysis in Medical Imaging”</li>
</ul></li>
<li>National Council on Radiation Protection and Measurement (NCRP)
<ul>
<li>Report 151 (2005) “Structural Shielding Design and Evaluation for Megavoltage X- and Gamma-Ray Radiotherapy Facilities”</li>
<li>Report 160 (2009) “Ionizing Radiation Exposure of the Population of the United States”</li>
</ul></li>
<li>American College of Radiology (ACR)</li>
<li>American Society of Radiotherapy (ASTRO)</li>
<li>The Joint Commission on Accreditation of Healthcare Organizations (<a href="https://www.jointcommission.org/accreditation/accreditation_main.aspx">JCAHO</a>)</li>
<li>American Association of Physicists in Medicine (AAPM)</li>
</ul>
<p>If you are an AAPM member, you can read pubished reports ICRP, ICRU, and NCRP from <a href="https://www.aapm.org/pubs/default.asp">here</a>.</p>
</div>
</div>
<div id="sources-of-radiation-exposure" class="section level2">
<h2><span class="header-section-number">16.2</span> Sources of radiation exposure</h2>
<p>According to the NCRP Report 160, the average annual radiation dose per person in the U.S. is about <strong>6.2 mSv</strong> (see next section), in which medical imaging contributes about 50% (e.g. CT: 24%, NM: 12%, interventional fluoroscopy 7%, conventional radiography 5%). Naturally occurring sources of radiation include cosmic radiation<a href="#fn2" class="footnoteRef" id="fnref2"><sup>2</sup></a> (5%), radioactive minerals in the ground and in your body (5%), and terrestrial radiation emitted by naturally occurring materials such as uranium, thorium, and radon (37%) in earth.</p>
<div class="figure" style="text-align: center"><span id="fig:dose-pie"></span>
<img src="figures/dose-pie-chart.png" alt="The pie chart of sources of radiation exposure from NCRP 160 can be found [here](https://www.epa.gov/radiation/radiation-sources-and-doses)." width="100%" />
<p class="caption">
Figure 16.1: The pie chart of sources of radiation exposure from NCRP 160 can be found <a href="https://www.epa.gov/radiation/radiation-sources-and-doses">here</a>.
</p>
</div>
</div>
<div id="effects-of-radiation-exposure" class="section level2">
<h2><span class="header-section-number">16.3</span> Effects of Radiation Exposure</h2>
<p>The sensitivity of cells to irradiation is in direct proportion to their <strong>reproductive</strong> activity and inversely proportional to their <strong>degree of differentiation</strong>.</p>
<p>Exposure to ionizing radiation can produce several effects in an individual, depending on the <strong>type and amount</strong> of radiation producing the exposure, the <strong>fraction of the body</strong> that is exposed, the general health of the exposed individual, the quality of medical care available in the event of a relatively high exposure.</p>
<div id="stochastic-probabilistic-effects" class="section level3">
<h3><span class="header-section-number">16.3.1</span> Stochastic (probabilistic) effects</h3>
<p>Biological effects (such as carcinogenesis, teratogenesis, and mutagenesis) that appear several months or years after exposure to radiation have several characteristics in common:<a href="#fn3" class="footnoteRef" id="fnref3"><sup>3</sup></a></p>
<ul>
<li>The <strong>probability</strong> of occurrence of the effect (i.e., the number of persons in an exposed population who exhibit the effect) increases with dose;</li>
<li>The <strong>severity</strong> of the effect in a single individual is unrelated to the magnitude of the dose (i.e., the effect is an “all or none” response);</li>
<li><strong>No definitive threshold</strong> exists below which it can be said with certainty that the effect will not occur.</li>
</ul>
<div class="figure" style="text-align: center"><span id="fig:lnt"></span>
<img src="figures/LNT_protection.png" alt="Glaus W. The concept and philosophy of permissible dose to radiation (1958)." width="70%" />
<p class="caption">
Figure 16.2: Glaus W. The concept and philosophy of permissible dose to radiation (1958).
</p>
</div>
</div>
<div id="deterministic-radiation-effects" class="section level3">
<h3><span class="header-section-number">16.3.2</span> Deterministic radiation effects</h3>
<p>Deterministic effects are those effects that exhibit a dose threshold. Those acute effects, known as <db>acute radiation syndromes</db> (ARS), is an acute illness caused by irradiation of the <strong>entire</strong> body (or most of the body) by <strong>high dose</strong> of penetrating radiation in a very <strong>short</strong> period of time (~minutes). ARSs include:</p>
<ul>
<li>hematopoietic (bone marrow) syndrome (0. Gy to 10 Gy)</li>
<li>gastrointestinal syndrome (&gt; 10 Gy)</li>
<li>cerebrovascular syndrome (&gt; 50 Gy).</li>
</ul>
<p class="question">
<em>Which of the following is best described as a stochastic event? a) Skin erythema; b) Epilation (hair loss); c) Lens opacification; d) Tissue necrosis; e) None of the above.</em> <br></br> Answer: <ab>e</ab>
</p>
<iframe width="100%" height="355" src="https://www.youtube.com/embed/uzqsnxZBLNE" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen>
</iframe>
<p>You would be exposed to about 0.035 mSv (another estimation is 1-3 <span class="math inline">\(\mu\)</span>Sv/h) of cosmic radiation if you were to fly within the United States from the east coast to the west coast, which is still less than that from a chest x-ray (Personal Annual Radiation Dose Calculator from NRC could be found <a href="https://www.nrc.gov/about-nrc/radiation/around-us/calculator.html">here</a>).</p>
<p class="question">
<em>Estimate the radiation dose to a medical physicist/radiation oncologist during a breast IORT procedure.</em> <br></br> If the reading from survey meter is about 200 mR/hr and delivery time is half an hour, the radiation reaches the whole body (after lead apron ~0.5 mm thickness, it is about one TVL for x-ray with 50 kvp) will be about 10 mR which is about <span class="boxed">0.1 mSv</span>.
</p>
</div>
</div>
<div id="dosimetric-quantities-for-radiation-safety" class="section level2">
<h2><span class="header-section-number">16.4</span> Dosimetric Quantities for Radiation Safety</h2>
<blockquote>
<p>There are a number of reasons for the confusion. In part, it’s the usual disparity between standard metric units and the less-standard units favored in the United States, added to the general confusion of reporters dealing with a fast-changing situation (for example, some early reports mixed up microsieverts with millisieverts — a thousandfold difference in dose). Others are more subtle: The difference between the raw physical units describing radiation emitted by a radioactive material (measured in units like curies and becquerels), versus measurements designed to reflect the different amounts of radiation energy absorbed by a mass of material (measured in rad or gray), and those that measure the relative biological damage in the human body (using rem and sieverts), which depends on the type of radiation.</p>
<footer>
— <a href="http://news.mit.edu/2011/explained-radioactivity-0328">Explained: rad, rem, sieverts, becquerels</a>
</footer>
</blockquote>
<div id="equivalent-dose" class="section level3">
<h3><span class="header-section-number">16.4.1</span> Equivalent dose</h3>
<p>The equivalent dose is the mean absorbed dose in a tissue or organ (D<sub>T,R</sub>) weighted by the <db>radiation weighting factor</db> (w<sub>R</sub>) for the type and energy of radiation:</p>
<span class="math display" id="eq:eq-dose">\[\begin{equation}
    H_{T,R} = \sum_R w_R \times D_{T,R}.
    \tag{16.1}
\end{equation}\]</span>
<p>The <span class="math inline">\(w_R\)</span> is equal to 1 for photons and electrons, 2 for protons, and 20 for <span class="math inline">\(\alpha\)</span> particles, fission fragments, and heavy ions.</p>
</div>
<div id="effective-dose-e" class="section level3">
<h3><span class="header-section-number">16.4.2</span> Effective dose (E)</h3>
<p>Effective dose applies <strong>only</strong> to stochastic effects. The effective dose is the sum over specified organs and tissues of the products of the equivalent dose in an organ or tissue (H<sub>T</sub>) and the <db>tissue weighting factor</db> for that organ or tissue (w<sub>T</sub>):</p>
<span class="math display" id="eq:eff-dose">\[\begin{equation}
    E = \sum_T w_T \times H_T,
    \tag{16.2}
\end{equation}\]</span>
<p>The tissue weighting factors have been developed from a reference population of equal numbers of both males and females and a wide range of ages (<a href="http://www.icrp.org/publication.asp?id=ICRP%20Publication%20103">ICRP #103</a>).</p>
<p>The SI unit for equivalent dose and effective dose is joule per kilogram (J/kg) with the special name <db>Sievert</db> (Sv) (<a href="https://ncrponline.org/wp-content/themes/ncrp/PDFs/NCRP-Composite-Glossary.pdf">ref</a>). Because 1 Sv is rather large quantity ((equal to 1 Gy numerically), the milliSievert (mSv) is commonly used in practice<a href="#fn4" class="footnoteRef" id="fnref4"><sup>4</sup></a>.</p>
<p class="question">
<em>A chest x-ray delivers an absorbed dose of 10 mrad to the lungs. a) What is the value of the effective dose? b) What is the risk of developing a fatal cancer as a result of this x-ray exam?</em> <br></br> a) The unit of rad is a depreciated unit for the absorbed dose, and 1 rad = 1 cGy. Based on ICRP report 103 Table 3, the weighting factor for lung is 0.12. Using Eq. <a href="protection.html#eq:eq-dose">(16.1)</a> and <a href="protection.html#eq:eff-dose">(16.2)</a>, <span class="math inline">\(E = w_{T=Lung} \times (w_{R=Photon} \times D_{T=Lung, R=Photon}) =\)</span> <span class="boxed">0.012 mSv</span>.<br />
b) According to the NRC, the risk is the excess lifetime risk of developing a fatal cancer due to radiation exposure is 4 <span class="math inline">\(\times\)</span> 10<sup>-2</sup> Sv<sup>-1</sup>. Therefore, the risk is 0.012 mSv <span class="math inline">\(\times\)</span> 4 <span class="math inline">\(\times\)</span> 10<sup>-2</sup> Sv<sup>-1</sup> = <ab>4.8 <span class="math inline">\(\times\)</span> 10<sup>-7</sup></ab>.
</p>
<p class="FOO">
<em>If the annual effective dose from radon exposure is 200mrem</em>
</p>
<ol start="5" style="list-style-type: decimal">
<li>Exposure to radiation has been shown to cause genetic effects in humans? True or False.</li>
<li>Of the 120,000 atomic bomb survivors that have been followed, the total number of excess cancers as of 1990 has been _____sfasdfasdf______.</li>
<li><p>The effective dose from a CT scan is approximately ________ times the average annual effective dose.</p></li>
<li>There is some evidence that a few abdominal x-ray images of a pregnant patient can double the likelihood of childhood cancer. True or False.</li>
<li>Which personnel must wear radiation badges?</li>
<li>What is the purpose of the use of filters in radiation badges? CHAP.</li>
<li>An 18 MV linac treats 40 patients per day, 5 days per week. If the average number of fields per patient is 2 and the average dose per field is 100 cGy, what is the workload for primary barriers?</li>
<li>What is the numerical value of the use factor in a secondary barrier calculation? Why?</li>
<li></li>
</ol>
<ol style="list-style-type: lower-alpha">
<li>What materials are used to shield against neutrons in radiation therapy room doors?</li>
<li>What types of linacs require such shielding?</li>
</ol>
<ol start="16" style="list-style-type: decimal">
<li>Three therapists work at the treatment console of a linear accelerator. What value should be used for the occupancy factor? Justify your answer.</li>
<li><p>What is the current NRC total effective dose limit for a) radiation workers and b) members of the general public?</p></li>
<li>What information is required as part of the written directive for a high dose rate brachytherapy treatment?</li>
<li><p>Under what conditions can a patient with a radioactive implant be released from the hospital?</p></li>
</ol>
<p>To avoid unacceptable complications, normal tissue should be below a <ab>tolerance dose</ab> (TD) (Emami et al.) Complications is categorized as fatal, severe (e.g. grade 3-4 pneumonitis), and quality-of-life complications. TD5%/5 and TD50%/5 are used to imply complications in 5 years.</p>
</div>
</div>
<div id="principles-of-radiation-protection" class="section level2">
<h2><span class="header-section-number">16.5</span> Principles of Radiation Protection</h2>
<div id="tds-rule" class="section level3">
<h3><span class="header-section-number">16.5.1</span> TDS rule</h3>
<p>Time (<span class="math inline">\(D \propto \dot{D}\times \Delta t\)</span>), distance (inverse square law), and shield (attenuation) measures are major factors in consideration of minimizing the unavoidable radiation exposure. Other procedures to minimize the exposure are containment and NRC’s system for radiation protection according to <a href="http://www.nrc.gov/about-nrc/radiation/protects-you/protection-principles.html">NRC guidelines</a>. The NRC’s system for protection includes:</p>
<ul>
<li>dose limits for radiation workers and members of the public;</li>
<li>monitoring and labeling radioactive materials;</li>
<li>posting signs in and around radiation areas;</li>
<li>reporting the theft or loss of radioactive material.</li>
</ul>
<p>In addition, the NRC imposes penalties for failures to follow the agency’s regulations.</p>
</div>
<div id="alara" class="section level3">
<h3><span class="header-section-number">16.5.2</span> ALARA</h3>
<p>As low as reasonally achivable</p>
</div>
<div id="dose-limits" class="section level3">
<h3><span class="header-section-number">16.5.3</span> Dose limits</h3>
<div class="figure" style="text-align: center"><span id="fig:eff-dose-limit"></span>
<img src="figures/effdoselimit.png" alt="Dose limits from NCRP report 116  [&quot;Limitation of Exposure to Ionizing Radiation&quot;](https://ncrponline.org/publications/reports/ncrp-reports-116/)." width="80%" />
<p class="caption">
Figure 16.3: Dose limits from NCRP report 116 <a href="https://ncrponline.org/publications/reports/ncrp-reports-116/">“Limitation of Exposure to Ionizing Radiation”</a>.
</p>
</div>
</div>
</div>
<div id="shielding-calculation" class="section level2">
<h2><span class="header-section-number">16.6</span> Shielding Calculation</h2>
<p>This design goal for an <ab>uncontrolled area</ab> is <strong>0.02 mSv/week</strong> (about 1 mSv annually for frequent or continuous exposure) or for a <ab>controlled area</ab> is <strong>0.1 mSv/week</strong> (about 5 mSv annually – this is lower than the recommended value of 50 mSv but is based upon the ALARA principle).</p>
<div id="dosimetric-quantities-for-shielding-design" class="section level3">
<h3><span class="header-section-number">16.6.1</span> Dosimetric Quantities for Shielding Design</h3>
<p>The quantity recommended in NCRP Publication 151 for shielding design calculations when neutrons and photons are present is <ab>dose equivalent</ab> (H). Dose equivalent is defined as the product of the <db>quality factor</db>, (QL), for a particular type of ionizing radiation and the absorbed dose (D) from that type of radiation at a point in tissue (ICRU Publication, 1993). The units of dose equivalent are also J/kg with the special name sievert (Sv).</p>
<table class="table" style="width: auto !important; margin-left: auto; margin-right: auto;">
<caption>
<span id="tab:let">Table 16.1: </span>Quality factor relationship
</caption>
<thead>
<tr>
<th style="text-align:left;">
Unrestricted linear energy transfer L (kV/<span class="math inline">\(\mu\)</span>m)
</th>
<th style="text-align:left;">
Quality factor Q(L)
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
<span class="math inline">\(\lt\)</span> 10
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
10-100
</td>
<td style="text-align:left;">
0.3L-2.2
</td>
</tr>
<tr>
<td style="text-align:left;">
<span class="math inline">\(\gt\)</span> 100
</td>
<td style="text-align:left;">
300/<span class="math inline">\(\sqrt{L}\)</span>
</td>
</tr>
</tbody>
<tfoot>
<tr>
<td style="padding: 0; border:0;" colspan="100%">
<sup>a</sup> From <a href="https://www.sciencedirect.com/science/article/pii/S0146645303000241">ICRP Publication 92</a>
</td>
</tr>
</tfoot>
</table>
<p>Fortunatley, the quality factor and radiation weight factor is the same (1) for high energy x and gamma-ray.</p>
</div>
<div id="workload-w" class="section level3">
<h3><span class="header-section-number">16.6.2</span> Workload (W)</h3>
<p>The average absorbed dose of radiation produced by a source over a specified time (a week) at a specific location (isocenter).</p>
<ul>
<li>Maximum 450 Gy/wk for single energy linac</li>
<li>Maximum 250 Gy/wk at high MV for dual energy</li>
</ul>
</div>
<div id="occupancy-factor" class="section level3">
<h3><span class="header-section-number">16.6.3</span> Occupancy factor</h3>
<p>The occupancy factor for an area is the average fraction of time that the maximally exposed individual is present while the beam is on.</p>
<table class="table" style="margin-left: auto; margin-right: auto;">
<caption>
<span id="tab:occupancy">Table 16.2: </span>Recommendation of ocuupacy factors (T)
</caption>
<thead>
<tr>
<th style="text-align:left;">
Location
</th>
<th style="text-align:right;">
T
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Full occupancy areas ( control rooms, nurse stations, attended waiting rooms)
</td>
<td style="text-align:right;">
1.000
</td>
</tr>
<tr>
<td style="text-align:left;">
Adjacent treatment room and patient examination room
</td>
<td style="text-align:right;">
0.500
</td>
</tr>
<tr>
<td style="text-align:left;">
Corridors, employee lounges
</td>
<td style="text-align:right;">
0.200
</td>
</tr>
<tr>
<td style="text-align:left;">
Treatment vault doors
</td>
<td style="text-align:right;">
0.125
</td>
</tr>
<tr>
<td style="text-align:left;">
Public toilets, unattended waiting rooms, storage areas, outdoor areas with seating, attics
</td>
<td style="text-align:right;">
0.050
</td>
</tr>
<tr>
<td style="text-align:left;">
Outdoor parking, drop off areas, stairways, unattended elevators
</td>
<td style="text-align:right;">
0.025
</td>
</tr>
</tbody>
<tfoot>
<tr>
<td style="padding: 0; border:0;" colspan="100%">
<sup>a</sup> From NCRP Publication 151 <a href="https://ncrponline.org/publications/reports/ncrp-reports-151/">Structural Shielding Design and Evaluation for Megavoltage X- and Gamma-Ray Radiotherapy Facilities</a>
</td>
</tr>
</tfoot>
</table>
</div>
<div id="use-factor-u" class="section level3">
<h3><span class="header-section-number">16.6.4</span> Use factor (U)</h3>
<p>Use Factor (U) is the fraction of the workload for which the primary beam is directed at the barrier in question.</p>
<table class="table" style="width: auto !important; margin-left: auto; margin-right: auto;">
<caption>
<span id="tab:t90">Table 16.3: </span>90<sup>o</sup> gantry angle intervals
</caption>
<thead>
<tr>
<th style="text-align:left;">
Angle interval center
</th>
<th style="text-align:left;">
U (percent)
</th>
<th style="text-align:left;">
Standard deviation (percent)
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
0<sup>o</sup>
</td>
<td style="text-align:left;">
31.0
</td>
<td style="text-align:left;">
3.7
</td>
</tr>
<tr>
<td style="text-align:left;">
90<sup>o</sup> or 270<sup>o</sup>
</td>
<td style="text-align:left;">
21.3 (each)
</td>
<td style="text-align:left;">
4.7
</td>
</tr>
<tr>
<td style="text-align:left;">
180<sup>o</sup>
</td>
<td style="text-align:left;">
26.3
</td>
<td style="text-align:left;">
3.7
</td>
</tr>
</tbody>
<tfoot>
<tr>
<td style="padding: 0; border:0;" colspan="100%">
<sup>a</sup> From NCRP Publication 151
</td>
</tr>
</tfoot>
</table>
</div>
<div id="primary-barrier" class="section level3">
<h3><span class="header-section-number">16.6.5</span> Primary barrier</h3>
<p>The <ab>primary barrier</ab> is designed and constructed to attenuation useful high energy and high dose rate beams.</p>
<span class="math display" id="eq:trans-primary">\[\begin{equation}
B_{pri}=\frac{P_{pri}d_{pri}^2}{WUT}
\tag{16.3}
\end{equation}\]</span>
<ul>
<li>P: shielding design goal (controlled area: 0.1 mSv/week and uncontrolled area: 0.02 mS/week); unit: mSv/week</li>
<li>d<sub>pri</sub>: distance from the target to the point of protection; no unit</li>
<li>W: workload (dose) at the isocenter; unit: [mSv/week]</li>
<li>U: use factor;</li>
<li>T: occupancy factor</li>
</ul>
</div>
<div id="secondary-barrier" class="section level3">
<h3><span class="header-section-number">16.6.6</span> Secondary barrier</h3>
<span class="math display" id="eq:leakage-2nd">\[\begin{equation}
    B_L=\frac{P_Ld_L^2}{0.001\cdot WT}
    \tag{16.4}
\end{equation}\]</span>
<span class="math display" id="eq:sca-2nd">\[\begin{equation}
    B_{sca}=\frac{P_{sca}}{\alpha WT}d_{sca}^2d_{sec}^2\frac{400}{F}
    \tag{16.5}
\end{equation}\]</span>
<div class="figure" style="text-align: center"><span id="fig:tvl"></span>
<img src="figures/TVL.png" alt="THe first and equivalent tenth-value layer for concrete, steel, and lead." width="40%" />
<p class="caption">
Figure 16.4: THe first and equivalent tenth-value layer for concrete, steel, and lead.
</p>
</div>
<p class="question">
<p><em>The control room of an 18 MV linear accelerator is shielded by the primary concrete barrier of the treatment room. When the beam is pointed toward the control room, the distance from the linac target to a point of protection (1 ft beyond the wall) is 6.6 m. a) Assuming a workload of 103 Sv/wk, what barrier transmission is necessary to reduce the exposure to 0.1 mSv/wk? b) How many TVL are necessary? c) If the TVL for an 18 MV beam is 43 cm in concrete, what is the required thickness of this primary barrier?</em></p>
</p>
</div>
<div id="conservation" class="section level3">
<h3><span class="header-section-number">16.6.7</span> Conservation</h3>
<p>The conservative safe nature of the shielding design includes:</p>
<ul>
<li>attenuation of the primary beam by the patient is neglected (30%);</li>
<li>perpendicular beam incident;</li>
<li>maximum leakage (0.001) radiations form the equipment;</li>
<li>recommended high occupancy factors for uncontrolled areas;</li>
<li>a distance of 0.3 m from the wall (most likely it is more than 0.3 m from the wall);</li>
<li>the “two-source” rule: more penetrating radiation is selected.</li>
</ul>
<p class="question">
<em>In designing structural shielding for a 10 MV linear accelerator vault, the beam quality is taken as: a) 10 MV for the primary beam, b) 10 MV for the leakage radiation, c) 3.3 MV for the scattered radiation at all angles, and d) 0.511 MeV for scattered radiation at 90°.</em> <br></br> The shield design is very conservative. When considering the beam energy for barriers, the highest possible beam energy is used in the calculation. (a, b, d)
</p>
<p>2017 AAPM Annual Meeting <a href="https://www.aapm.org/education/sams/Default.asp?v=true&amp;mid=127&amp;qid=2563">Strategies for Quality Improvement Based On RO-ILS Information</a></p>
</div>
</div>
<div id="survey" class="section level2">
<h2><span class="header-section-number">16.7</span> Survey</h2>
<p>A radiation survey is required after linacs are installed in the vault. Typically, a Geiger-Müller (GM) counter, a large-volume pressurized ion chamber, and a BF<sub>3</sub> proportional counter (if high energy photons are installed) are used to perform this task.</p>
<div id="detectors" class="section level3">
<h3><span class="header-section-number">16.7.1</span> Detectors</h3>
<p class="question">
<p><em>Which of the following detectors may be used to determine the adequacy of a primary barrier? a) Ionization chamber survey meter; b) Geiger-Müller (GM) counter; c) Farmer-type ionization chamber; d) Scintillation detector; and e)BF<sub>3</sub> proportional counter</em></p>
Answer: <ab>a)</ab>
</p>
<p>A <ab>GM counter</ab> is used to detect the <strong>presence</strong> of radiation, which consists of a tube filled with lower pressure (~ 0.1 atmosphere) inert gas (98% helium and 1.3% butane). For radiation survey, it is used to detect potentially unexpected large exposure due to deviation of construction from the planned schematic. In contrast to measuring average current produced over <strong>many interactions</strong> as in an ion chamber, the reading is recorded for each <strong>individual</strong> interaction in a GM detector. Therefore, a GM counter suffers its inability (due to <ab>dead time</ab><a href="#fn5" class="footnoteRef" id="fnref5"><sup>5</sup></a> of the tube) to measure high exposure rate from a linac even behind barriers. In addition, a GM counter cannot distinguish the energy (e.g. 6 MV and 15 MV) of the incident radiation.</p>
<div class="figure" style="text-align: center"><span id="fig:gm"></span>
<img src="figures/GM_counter.jpg" alt="A GM counter with a pancake probe ([wiki](https://en.wikipedia.org/wiki/Geiger_counter.))" width="70%" />
<p class="caption">
Figure 16.5: A GM counter with a pancake probe (<a href="https://en.wikipedia.org/wiki/Geiger_counter.">wiki</a>)
</p>
</div>
<p>A (large volume pressurized ion chamber) <db>survey meter</db> is used to quantify the exposure behind barriers.</p>
<iframe width="100%" height="355" src="https://www.youtube.com/embed/UYPJQNVeC_I" frameborder="0" allowfullscreen>
</iframe>
<p>A <db>farmer-type ionization chamber</db> is most commonly used for linac output measurements. It is not suitable for survey measurement due to its small detection volume, about 0.6 cc (about 230 cc for a <a href="https://www.flukebiomedical.com/products/radiation-measurement/radiation-safety/451p-radiation-detector-pressurized">Fluke 451P survey meter</a>).</p>
<p>A <db>scintillation detector</db> is designed (a scintillator plus a photo-multiplier) to detect small signals. For example, a liquid scintillation counter is used to detect removable I-125 contamination on swabs. According to the NRC’s guideline on the seed localization for low dose rate brachytherapy, a low energy gamma scintillation survey meter is required for as a part of emergency response equipment (others include gloves, reverse action tweezers, shielded containers, and caution radioactive material (CRAM) labels.</p>
<p>A <db>BF<sub>3</sub> proportional counter</d
b> is most commonly used for neutron detection. A BF<sub>3</sub> counter is an active monitoring (passive monitoring: bubble detectors, TLDs) device that uses Boron to capture neutrons.</p>
<p>More information about radiation monitoring devices can be found on IAEA <a href="https://international.anl.gov/training/materials/IAEA%20Publications/Radiation%20Oncology%20Physics%20Handbook/Radiation%20Oncology%20Physics%20-%20Slides%20-%20pdf/Chapter_04_Radiation_monitoring_instruments.pdf">presentation</a>.</p>
</div>
<div id="patient-release" class="section level3">
<h3><span class="header-section-number">16.7.2</span> Patient release</h3>
<p>A licensee may release a patient with radiopharmaceutical material only if it is ensured that the activity remaining in the patient is less than <strong>30 <span class="math inline">\(\mu\)</span>Ci</strong> and the dose rate at 1 m from the patient is less than <strong>5 mrem/hr</strong>.</p>

</div>
</div>
</div>
<div class="footnotes">
<hr />
<ol start="2">
<li id="fn2"><p>Cosmic radiation is produced when primary photons and α particles from outside the solar system interact with components of the earth’s atmosphere. A second source of cosmic radiation is the release of charged particles from the sun, which become significant during periods of solar flare (‘sun storm’).<a href="protection.html#fnref2">↩</a></p></li>
<li id="fn3"><p>Precise estimates of the role of an initiating agent such as radiation in producing stochastic effects are difficult to obtain because the effects also occur in the absence of radiation.<a href="protection.html#fnref3">↩</a></p></li>
<li id="fn4"><p>Historically, the unit of millirem (mrem) was widely used in US (rem stands for <db>Roentgen Equivalent Man</db>). The relationship between mSv and mrem is, 1 mSv = 100 mrem.<a href="protection.html#fnref4">↩</a></p></li>
<li id="fn5"><p>The <ab>dead time</ab> is the time it takes for the GM detector to reset (for the readout circuit). During this reset process, the GM counter does not measure any radiation.<a href="protection.html#fnref5">↩</a></p></li>
</ol>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="brachy.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="qa.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"google": false,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "linkedin", "weibo", "instapaper"],
"instapper": false
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": null,
"history": {
"link": null,
"text": null
},
"download": null,
"toc": {
"collapse": "subsection",
"scroll_highlight": true
},
"toolbar": {
"position": "fixed"
},
"search": true
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
